berberine has been researched along with Colitis Gravis in 38 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study explored the synergetic effects of berberine and 6-shogaol, the primary components of Coptidis Rhizoma and Zingiberis Rhizoma, respectively, on intestinal inflammation and intestinal flora in mice with ulcerative colitis to reveal the effect and mechanism of cold-heat combination in the treatment of ulcerative colitis." | 8.12 | [Experimental study on effects of berberine combined with 6-shogaol on intestinal inflammation and flora in mice with ulcerative colitis]. ( Chen, ZG; Li, JT; Wei, HL; Yan, SG, 2022) |
| "This study focuses on constructing of an anti-inflammatory drug delivery system by encapsulation of berberine in the β-glucan nanoparticles and evaluates its effect on treating ulcerative colitis." | 8.12 | Macrophage-Targeted Berberine-Loaded β-Glucan Nanoparticles Enhance the Treatment of Ulcerative Colitis. ( Chen, Q; Fan, Y; Huang, J; Liang, M; Long, H; Wang, Y; Wang, Z; Wu, C; Xu, Y, 2022) |
| "Berberine (BBR), a compound long used in traditional Chinese medicine, has been reported to have therapeutic effects in treating ulcerative colitis (UC), attributed to its anti-inflammatory properties and restorative potential of tight junctions (TJs)." | 8.02 | Berberine inhibits dendritic cells differentiation in DSS-induced colitis by promoting Bacteroides fragilis. ( Hassan, S; Wang, Y; Xu, G; Xu, Y; Zhang, M; Zheng, C; Zhou, L; Zou, X, 2021) |
| " Although berberine, an isoquinoline alkaloid, has been revealed to exert protective effects on experimental colitis, the underlying molecular mechanism in chronic intestinal inflammation remains ill-defined." | 7.96 | Intervention of oncostatin M-driven mucosal inflammation by berberine exerts therapeutic property in chronic ulcerative colitis. ( Fan, C; Feng, C; He, P; Li, H; Lu, H; Lu, Q; Tang, W; Xiang, C; Yang, X; Yang, Y; Zhang, Z; Zhu, F; Zuo, J, 2020) |
| " Moreover, the thick colonic mucus layer obstructs the penetration of the drug, resulting in low bioavailability to the inflammatory site of the colon." | 5.72 | Mucus-Penetrating Alginate-Chitosan Nanoparticles Loaded with Berberine Hydrochloride for Oral Delivery to the Inflammation Site of Ulcerative Colitis. ( Chen, S; Fang, W; Gao, S; Hu, R; Lu, W; Nie, X; Sun, L; Zhang, Q, 2022) |
| "The present study explored the synergetic effects of berberine and 6-shogaol, the primary components of Coptidis Rhizoma and Zingiberis Rhizoma, respectively, on intestinal inflammation and intestinal flora in mice with ulcerative colitis to reveal the effect and mechanism of cold-heat combination in the treatment of ulcerative colitis." | 4.12 | [Experimental study on effects of berberine combined with 6-shogaol on intestinal inflammation and flora in mice with ulcerative colitis]. ( Chen, ZG; Li, JT; Wei, HL; Yan, SG, 2022) |
| "This study focuses on constructing of an anti-inflammatory drug delivery system by encapsulation of berberine in the β-glucan nanoparticles and evaluates its effect on treating ulcerative colitis." | 4.12 | Macrophage-Targeted Berberine-Loaded β-Glucan Nanoparticles Enhance the Treatment of Ulcerative Colitis. ( Chen, Q; Fan, Y; Huang, J; Liang, M; Long, H; Wang, Y; Wang, Z; Wu, C; Xu, Y, 2022) |
| "Berberine (BBR), a compound long used in traditional Chinese medicine, has been reported to have therapeutic effects in treating ulcerative colitis (UC), attributed to its anti-inflammatory properties and restorative potential of tight junctions (TJs)." | 4.02 | Berberine inhibits dendritic cells differentiation in DSS-induced colitis by promoting Bacteroides fragilis. ( Hassan, S; Wang, Y; Xu, G; Xu, Y; Zhang, M; Zheng, C; Zhou, L; Zou, X, 2021) |
| " Although berberine, an isoquinoline alkaloid, has been revealed to exert protective effects on experimental colitis, the underlying molecular mechanism in chronic intestinal inflammation remains ill-defined." | 3.96 | Intervention of oncostatin M-driven mucosal inflammation by berberine exerts therapeutic property in chronic ulcerative colitis. ( Fan, C; Feng, C; He, P; Li, H; Lu, H; Lu, Q; Tang, W; Xiang, C; Yang, X; Yang, Y; Zhang, Z; Zhu, F; Zuo, J, 2020) |
| " 2) Mice with xylene-induced acute exudative edema and acetic acid-induced writhing." | 3.77 | Evidence for the complementary and synergistic effects of the three-alkaloid combination regimen containing berberine, hypaconitine and skimmianine on the ulcerative colitis rats induced by trinitrobenzene-sulfonic acid. ( Guo, Z; Li, C; Li, Q; Li, Y; Liu, L; Long, Y; Mei, Q; Niu, Y; Sun, Y; Wang, Y; Wu, H; Zhang, M, 2011) |
| "Berberine (BBR) is an effective drug for UC treatment." | 1.72 | Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway. ( Dong, Y; Fan, H; Fu, Y; Gui, Y; Guo, W; Hu, D; Jiang, F; Kang, Z; Li, J; Li, M; Luo, S; Sarapultsev, A; Shou, Z; Wang, H; Zhang, G; Zhang, Z; Zhou, H; Zhu, R, 2022) |
| " Moreover, the thick colonic mucus layer obstructs the penetration of the drug, resulting in low bioavailability to the inflammatory site of the colon." | 1.72 | Mucus-Penetrating Alginate-Chitosan Nanoparticles Loaded with Berberine Hydrochloride for Oral Delivery to the Inflammation Site of Ulcerative Colitis. ( Chen, S; Fang, W; Gao, S; Hu, R; Lu, W; Nie, X; Sun, L; Zhang, Q, 2022) |
| " Currently, there is a considerable need for the development of orally bioavailable dosage forms that enable the effective delivery of therapeutic drugs to local diseased lesions in the gastrointestinal tract." | 1.62 | Orally Deliverable Dual-Targeted Pellets for the Synergistic Treatment of Ulcerative Colitis. ( Du, Y; Gu, Y; Jiang, L; Liu, J; Tang, X; Yang, M, 2021) |
| "As a chronic inflammatory disease, ulcerative colitis (UC) is relevant to a rising risk of colorectal cancer." | 1.62 | Dihydroberberine, an isoquinoline alkaloid, exhibits protective effect against dextran sulfate sodium-induced ulcerative colitis in mice. ( Dong, N; Li, C; Lu, Q; Mo, Z; Wu, B; Xie, J, 2021) |
| "In vivo, the effect of BBHon ulcerative colitiswas alsoinvestigated." | 1.56 | Design, synthesis and evaluation of a baicalin and berberine hybrid compound as therapeutic agent for ulcerative colitis. ( Chen, K; Cong, W; Dou, Y; Gao, Y; Jia, D; Li, W; Li, Z; Ma, M; Wu, Z; Zhou, X, 2020) |
| "Berberine hydrochloride has beneficial effects in UC." | 1.51 | Protective effects of berberine hydrochloride on DSS-induced ulcerative colitis in rats. ( Gu, P; Shen, H; Zhu, L, 2019) |
| "8-Oxocoptisine showed significant anti-ulcerative colitis efficacy in vitro with EC50 value being 8." | 1.40 | New synthetic method of 8-oxocoptisine starting from natural quaternary coptisine as anti-ulcerative colitis agent. ( Deng, AJ; Li, ZH; Qin, HL; Wang, WJ; Wu, LQ; Yu, JQ; Zhang, HJ; Zhang, ZH, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (2.63) | 29.6817 |
| 2010's | 9 (23.68) | 24.3611 |
| 2020's | 28 (73.68) | 2.80 |
| Authors | Studies |
|---|---|
| Li, B | 1 |
| Li, H | 2 |
| Zhu, Z | 1 |
| Xiang, C | 2 |
| Xu, Z | 1 |
| Fan, C | 2 |
| Zhao, Y | 1 |
| Feng, C | 2 |
| Sun, H | 1 |
| Zhang, Y | 7 |
| Cai, T | 1 |
| Tang, W | 2 |
| Zhu, W | 1 |
| Tang, X | 1 |
| Yang, M | 2 |
| Gu, Y | 1 |
| Jiang, L | 1 |
| Du, Y | 1 |
| Liu, J | 2 |
| Zheng, C | 1 |
| Wang, Y | 9 |
| Xu, Y | 4 |
| Zhou, L | 1 |
| Hassan, S | 1 |
| Xu, G | 1 |
| Zou, X | 1 |
| Zhang, M | 5 |
| Lindh, MG | 1 |
| Mattsson, G | 1 |
| Koyi, H | 1 |
| Johansson, MB | 1 |
| Razmi, R | 1 |
| Palm, A | 1 |
| Centorrino, F | 1 |
| Andlovic, B | 1 |
| Cossar, P | 1 |
| Brunsveld, L | 1 |
| Ottmann, C | 1 |
| Hayashi, S | 1 |
| Takenaka, M | 1 |
| Hosono, M | 1 |
| Kogure, H | 1 |
| Hasatani, K | 1 |
| Suda, T | 1 |
| Maruyama, H | 1 |
| Matsunaga, K | 1 |
| Ihara, H | 1 |
| Yoshio, T | 1 |
| Nagaike, K | 1 |
| Yamada, T | 1 |
| Yakushijin, T | 1 |
| Takagi, T | 1 |
| Tsumura, H | 1 |
| Kurita, A | 1 |
| Asai, S | 1 |
| Ito, Y | 1 |
| Kuwai, T | 1 |
| Hori, Y | 1 |
| Maetani, I | 1 |
| Ikezawa, K | 1 |
| Iwashita, T | 1 |
| Matsumoto, K | 1 |
| Fujisawa, T | 1 |
| Nishida, T | 1 |
| Mwesigwa, PJ | 1 |
| Jackson, NJ | 1 |
| Caron, AT | 1 |
| Kanji, F | 1 |
| Ackerman, JE | 1 |
| Webb, JR | 1 |
| Scott, VCS | 1 |
| Eilber, KS | 1 |
| Underhill, DM | 1 |
| Anger, JT | 1 |
| Ackerman, AL | 1 |
| Shi, LY | 1 |
| Subramanian, A | 1 |
| Weng, L | 1 |
| Lee, S | 1 |
| Kisslinger, K | 1 |
| Nam, CY | 1 |
| Ross, CA | 1 |
| Yang, C | 1 |
| Yan, X | 1 |
| Ma, Y | 2 |
| Cao, Y | 2 |
| Xu, Q | 1 |
| Tu, K | 1 |
| Sato, Y | 1 |
| Song, Y | 2 |
| Geng, W | 1 |
| Yan, S | 2 |
| Nakamura, K | 1 |
| Kikukawa, T | 1 |
| Demura, M | 1 |
| Ayabe, T | 1 |
| Aizawa, T | 1 |
| Tsuji, K | 1 |
| Matsuoka, YJ | 1 |
| Kuchiba, A | 1 |
| Suto, A | 1 |
| Ochi, E | 1 |
| Zhou, G | 1 |
| Yang, Y | 2 |
| Jing, B | 1 |
| Sun, B | 1 |
| Hu, S | 2 |
| Liu, Z | 2 |
| Thakurata, DG | 1 |
| Das, KC | 1 |
| Dhar, SS | 1 |
| Dong, Y | 1 |
| Fan, H | 1 |
| Zhang, Z | 3 |
| Jiang, F | 1 |
| Li, M | 1 |
| Zhou, H | 2 |
| Guo, W | 1 |
| Kang, Z | 1 |
| Gui, Y | 1 |
| Shou, Z | 1 |
| Li, J | 2 |
| Zhu, R | 1 |
| Fu, Y | 2 |
| Sarapultsev, A | 1 |
| Wang, H | 1 |
| Luo, S | 1 |
| Zhang, G | 2 |
| Hu, D | 1 |
| Sun, L | 1 |
| Nie, X | 1 |
| Lu, W | 1 |
| Zhang, Q | 1 |
| Fang, W | 1 |
| Gao, S | 2 |
| Chen, S | 2 |
| Hu, R | 1 |
| Yan, Y | 1 |
| Li, L | 2 |
| Wu, K | 2 |
| Peng, L | 1 |
| Liang, Y | 1 |
| Wang, Z | 6 |
| Han, Q | 2 |
| Deng, LR | 1 |
| Zou, M | 2 |
| Tang, HZ | 2 |
| Huang, CY | 1 |
| Chen, FJ | 1 |
| Tomlinson, B | 1 |
| Li, YH | 4 |
| Wei, HL | 1 |
| Li, JT | 1 |
| Chen, ZG | 1 |
| Yan, SG | 1 |
| Chen, Z | 1 |
| Hao, W | 1 |
| Yuan, Q | 1 |
| Gao, C | 1 |
| Wu, X | 1 |
| Wang, S | 1 |
| Wu, C | 5 |
| Zheng, T | 1 |
| Chen, H | 1 |
| Zou, P | 1 |
| Wang, J | 4 |
| Li, N | 1 |
| Li, Y | 4 |
| Dong, Z | 1 |
| Li, X | 1 |
| Xu, S | 1 |
| Li, K | 2 |
| Gao, XJ | 1 |
| Guo, MY | 1 |
| Huang, J | 3 |
| Fan, Y | 3 |
| Long, H | 3 |
| Liang, M | 3 |
| Chen, Q | 3 |
| Zhu, C | 1 |
| Peng, XX | 1 |
| Yao, TJ | 1 |
| Wang, ZY | 1 |
| Hu, P | 1 |
| Cai, D | 1 |
| Liu, HY | 1 |
| Gao, F | 1 |
| Kong, JW | 1 |
| Wang, ZJ | 1 |
| Zheng, HC | 1 |
| Jiang, XQ | 1 |
| Xu, SJ | 1 |
| Li, SL | 1 |
| Lu, MJ | 1 |
| Dai, ZQ | 1 |
| Chu, FH | 1 |
| Xu, B | 1 |
| Lei, HM | 1 |
| Mahami, S | 1 |
| Salehi, M | 1 |
| Mehrabi, M | 1 |
| Vahedi, H | 1 |
| Hassani, MS | 1 |
| Bitaraf, FS | 1 |
| Omri, A | 1 |
| Wang, X | 1 |
| Liang, F | 1 |
| Dai, Z | 1 |
| Feng, X | 1 |
| Qiu, F | 1 |
| Xu, C | 1 |
| Zhao, L | 1 |
| Zhou, W | 1 |
| Hu, H | 1 |
| Xu, L | 1 |
| Xue, X | 1 |
| Li, ZS | 1 |
| Yang, GY | 1 |
| Pan, Y | 1 |
| Wen, A | 1 |
| Jia, Y | 1 |
| Rodriguez, LM | 1 |
| Tull, MB | 1 |
| Benante, K | 1 |
| Khan, SA | 1 |
| Jovanovic, B | 1 |
| Richmond, E | 1 |
| Umar, A | 1 |
| Bergan, R | 1 |
| Liao, Z | 2 |
| Zhang, S | 1 |
| Liu, W | 2 |
| Zou, B | 2 |
| Lin, L | 1 |
| Chen, M | 1 |
| Liu, D | 2 |
| Wang, M | 1 |
| Cai, Y | 2 |
| Liao, Q | 2 |
| Xie, Z | 2 |
| Xie, Y | 1 |
| Zhou, B | 1 |
| Xiao, D | 1 |
| Yang, X | 1 |
| Lu, H | 1 |
| Lu, Q | 2 |
| Zhu, F | 1 |
| He, P | 1 |
| Zuo, J | 1 |
| Zhao, J | 2 |
| Wang, L | 1 |
| Bian, ZX | 3 |
| Deng, J | 1 |
| Wu, Z | 2 |
| Zhao, Z | 1 |
| Yuan, M | 1 |
| Su, Z | 1 |
| Jia, D | 1 |
| Dou, Y | 1 |
| Li, Z | 1 |
| Zhou, X | 1 |
| Gao, Y | 1 |
| Chen, K | 1 |
| Cong, W | 1 |
| Ma, M | 1 |
| Li, W | 1 |
| Hou, D | 1 |
| Dang, S | 1 |
| Xiong, X | 1 |
| Cheng, Z | 1 |
| Wu, F | 1 |
| Hu, M | 1 |
| Dong, R | 1 |
| Chen, G | 1 |
| Wang, JJ | 1 |
| Ren, MH | 1 |
| Yang, XJ | 1 |
| Wang, LY | 1 |
| Li, C | 2 |
| Dong, N | 1 |
| Wu, B | 1 |
| Mo, Z | 1 |
| Xie, J | 1 |
| Zhu, L | 1 |
| Gu, P | 1 |
| Shen, H | 1 |
| Sun, W | 1 |
| Zhou, BJ | 1 |
| Rosenstein, A | 1 |
| Zhang, ZH | 4 |
| Wu, LQ | 4 |
| Deng, AJ | 4 |
| Yu, JQ | 1 |
| Li, ZH | 4 |
| Zhang, HJ | 4 |
| Wang, WJ | 4 |
| Qin, HL | 4 |
| Wang, B | 1 |
| Liu, Y | 1 |
| Xiao, HT | 1 |
| Fu, HB | 1 |
| Ho, A | 1 |
| Lin, CY | 1 |
| Huang, Y | 1 |
| Lin, G | 1 |
| Xie, M | 1 |
| Song, HR | 1 |
| Long, Y | 1 |
| Sun, Y | 1 |
| Li, Q | 1 |
| Wu, H | 1 |
| Guo, Z | 1 |
| Niu, Y | 1 |
| Liu, L | 1 |
| Mei, Q | 1 |
| Li, RZ | 1 |
| Liao, HW | 1 |
| Chen, FY | 1 |
2 reviews available for berberine and Colitis Gravis
| Article | Year |
|---|---|
Berberine a traditional Chinese drug repurposing: Its actions in inflammation-associated ulcerative colitis and cancer therapy.
Topics: Anti-Inflammatory Agents; Berberine; Colitis, Ulcerative; Drug Repositioning; Humans; Inflammation; | 2022 |
Berberine in the treatment of ulcerative colitis: A possible pathway through Tuft cells.
Topics: Animals; Anti-Inflammatory Agents; Berberine; Colitis, Ulcerative; Colon; Cytokines; Humans; Inflamm | 2021 |
1 trial available for berberine and Colitis Gravis
| Article | Year |
|---|---|
A Phase I Trial of Berberine in Chinese with Ulcerative Colitis.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Berberine; Biopsy; China; Coli | 2020 |
35 other studies available for berberine and Colitis Gravis
| Article | Year |
|---|---|
Discovery of chiral N-2'-aryletheryl-1'-alkoxy-ethyl substituted arylisoquinolones with anti-inflammatory activity from the nucleophilic addition reactions of the thiophenols and oxazolinium.
Topics: Animals; Anti-Inflammatory Agents; Colitis, Ulcerative; Dextran Sulfate; Dose-Response Relationship, | 2021 |
Orally Deliverable Dual-Targeted Pellets for the Synergistic Treatment of Ulcerative Colitis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Area Under Curve; Atractylodes; Berberine; | 2021 |
Berberine inhibits dendritic cells differentiation in DSS-induced colitis by promoting Bacteroides fragilis.
Topics: Animals; Anti-Inflammatory Agents; Bacteroides fragilis; Berberine; Cell Differentiation; Colitis; C | 2021 |
Topics: Adult; Air Pollution; alpha-Defensins; Amino Acid Sequence; Animals; Bacteria; Berberine; Breast Neo | 2022 |
Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway.
Topics: Animals; Berberine; beta Catenin; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Mode | 2022 |
Mucus-Penetrating Alginate-Chitosan Nanoparticles Loaded with Berberine Hydrochloride for Oral Delivery to the Inflammation Site of Ulcerative Colitis.
Topics: Administration, Oral; Alginates; Berberine; Chitosan; Colitis, Ulcerative; Drug Carriers; Drug Deliv | 2022 |
A Combination of Baicalin and Berberine Hydrochloride Ameliorates Dextran Sulfate Sodium-Induced Colitis by Modulating Colon Gut Microbiota.
Topics: Animals; Berberine; Colitis; Colitis, Ulcerative; Colon; Cytokines; Dextran Sulfate; Disease Models, | 2022 |
Anemoside B4 protects against chronic relapsing colitis in mice by modulating inflammatory response, colonic transcriptome and the gut microbiota.
Topics: Animals; Berberine; Colitis; Colitis, Ulcerative; Colon; Cytokines; Dextran Sulfate; Disease Models, | 2022 |
[Experimental study on effects of berberine combined with 6-shogaol on intestinal inflammation and flora in mice with ulcerative colitis].
Topics: Animals; Berberine; Catechols; Claudin-1; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Dise | 2022 |
Targeted delivery of Chinese herb pair-based berberine/tannin acid self-assemblies for the treatment of ulcerative colitis.
Topics: Animals; Antineoplastic Agents; Benzopyrans; Berberine; China; Colitis; Colitis, Ulcerative; Dextran | 2022 |
Effect and Mechanism of Pharmaceutical Excipients on Berberine to Alleviate Ulcerative Colitis via Regulating Gut Microbiota.
Topics: Animals; Berberine; Chitosan; Claudin-2; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disea | 2022 |
Berberine Depresses Inflammation and Adjusts Smooth Muscle to Ameliorate Ulcerative Colitis of Cats by Regulating Gut Microbiota.
Topics: Animals; Berberine; Cats; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Anim | 2022 |
Macrophage-Targeted Berberine-Loaded β-Glucan Nanoparticles Enhance the Treatment of Ulcerative Colitis.
Topics: Animals; Anti-Inflammatory Agents; Berberine; beta-Glucans; Colitis; Colitis, Ulcerative; Inflammati | 2022 |
Macrophage-Targeted Berberine-Loaded β-Glucan Nanoparticles Enhance the Treatment of Ulcerative Colitis.
Topics: Animals; Anti-Inflammatory Agents; Berberine; beta-Glucans; Colitis; Colitis, Ulcerative; Inflammati | 2022 |
Macrophage-Targeted Berberine-Loaded β-Glucan Nanoparticles Enhance the Treatment of Ulcerative Colitis.
Topics: Animals; Anti-Inflammatory Agents; Berberine; beta-Glucans; Colitis; Colitis, Ulcerative; Inflammati | 2022 |
Macrophage-Targeted Berberine-Loaded β-Glucan Nanoparticles Enhance the Treatment of Ulcerative Colitis.
Topics: Animals; Anti-Inflammatory Agents; Berberine; beta-Glucans; Colitis; Colitis, Ulcerative; Inflammati | 2022 |
Macrophage-Targeted Berberine-Loaded β-Glucan Nanoparticles Enhance the Treatment of Ulcerative Colitis.
Topics: Animals; Anti-Inflammatory Agents; Berberine; beta-Glucans; Colitis; Colitis, Ulcerative; Inflammati | 2022 |
Macrophage-Targeted Berberine-Loaded β-Glucan Nanoparticles Enhance the Treatment of Ulcerative Colitis.
Topics: Animals; Anti-Inflammatory Agents; Berberine; beta-Glucans; Colitis; Colitis, Ulcerative; Inflammati | 2022 |
Macrophage-Targeted Berberine-Loaded β-Glucan Nanoparticles Enhance the Treatment of Ulcerative Colitis.
Topics: Animals; Anti-Inflammatory Agents; Berberine; beta-Glucans; Colitis; Colitis, Ulcerative; Inflammati | 2022 |
Macrophage-Targeted Berberine-Loaded β-Glucan Nanoparticles Enhance the Treatment of Ulcerative Colitis.
Topics: Animals; Anti-Inflammatory Agents; Berberine; beta-Glucans; Colitis; Colitis, Ulcerative; Inflammati | 2022 |
Macrophage-Targeted Berberine-Loaded β-Glucan Nanoparticles Enhance the Treatment of Ulcerative Colitis.
Topics: Animals; Anti-Inflammatory Agents; Berberine; beta-Glucans; Colitis; Colitis, Ulcerative; Inflammati | 2022 |
[Therapeutic effect of ursodeoxycholic acid-berberine supramolecular nanoparticles on ulcerative colitis based on supramolecular system induced by weak bond].
Topics: Animals; Berberine; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Dr | 2023 |
pH-sensitive HPMCP-chitosan nanoparticles containing 5-aminosalicylic acid and berberine for oral colon delivery in a rat model of ulcerative colitis.
Topics: Animals; Berberine; Chitosan; Colitis, Ulcerative; Hydrogen-Ion Concentration; Mesalamine; Nanoparti | 2023 |
Combination of Coptis chinensis polysaccharides and berberine ameliorates ulcerative colitis by regulating gut microbiota and activating AhR/IL-22 pathway.
Topics: Animals; Berberine; Coleoptera; Colitis, Ulcerative; Coptis chinensis; Gastrointestinal Microbiome; | 2024 |
Synergistic effect of berberine hydrochloride and dehydrocostus lactone in the treatment of ulcerative colitis: Take gut microbiota as the target.
Topics: Animals; Berberine; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Ga | 2023 |
LC-MS-based metabolomics analysis of Berberine treatment in ulcerative colitis rats.
Topics: Amino Acids; Animals; Berberine; Chromatography, Liquid; Colitis, Ulcerative; Disease Models, Animal | 2019 |
Berberine ameliorates colonic damage accompanied with the modulation of dysfunctional bacteria and functions in ulcerative colitis rats.
Topics: Amino Acids; Animals; Bacteria; Berberine; Claudin-1; Colitis, Ulcerative; Colon; Dextran Sulfate; G | 2020 |
Intervention of oncostatin M-driven mucosal inflammation by berberine exerts therapeutic property in chronic ulcerative colitis.
Topics: Animals; Berberine; Chronic Disease; Colitis, Ulcerative; Humans; Inflammation; Intestinal Mucosa; M | 2020 |
Anti-inflammatory Efficacy of Combined Natural Alkaloid Berberine and S1PR Modulator Fingolimod at Low Doses in Ulcerative Colitis Preclinical Models.
Topics: Animals; Anti-Inflammatory Agents; Berberine; Cell Line, Tumor; Colitis, Ulcerative; Cytokines; Dext | 2020 |
Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Berberine; Caco-2 Cells; Colitis, Ulcerativ | 2020 |
Design, synthesis and evaluation of a baicalin and berberine hybrid compound as therapeutic agent for ulcerative colitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bacteria; Berberine; Colitis, Ulcerative; | 2020 |
To assess the effective and safety of berberine hydrochloride in ulcerative colitis: A protocol for systematic review and meta-analysis.
Topics: Berberine; Colitis, Ulcerative; Drugs, Chinese Herbal; Humans; Meta-Analysis as Topic; Randomized Co | 2020 |
[Research progress of effect of berberine in treatment of ulcerative colitis based on cell signaling pathway].
Topics: Berberine; Colitis; Colitis, Ulcerative; Humans; Intestinal Mucosa; Signal Transduction | 2021 |
Dihydroberberine, an isoquinoline alkaloid, exhibits protective effect against dextran sulfate sodium-induced ulcerative colitis in mice.
Topics: Animals; Berberine; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Isoquinolin | 2021 |
Protective effects of berberine hydrochloride on DSS-induced ulcerative colitis in rats.
Topics: Animals; Anti-Inflammatory Agents; Berberine; Colitis, Ulcerative; Cytokines; Dextran Sulfate; Disea | 2019 |
iTRAQ-based pharmacoproteomics reveals potential targets of berberine, a promising therapy for ulcerative colitis.
Topics: Animals; Berberine; Colitis, Ulcerative; Colon; Male; Mice; Mice, Inbred C57BL; Molecular Targeted T | 2019 |
New synthetic method of 8-oxocoptisine starting from natural quaternary coptisine as anti-ulcerative colitis agent.
Topics: Berberine; Berberine Alkaloids; Colitis, Ulcerative; Ferricyanides; Molecular Structure | 2014 |
Synthesis and Structure-Activity Relationships of Quaternary Coptisine Derivatives as Potential Anti-ulcerative Colitis Agents.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Berberine; Cell Line; Colitis, Ulcerative; Colon; | 2015 |
Addition of Berberine to 5-Aminosalicylic Acid for Treatment of Dextran Sulfate Sodium-Induced Chronic Colitis in C57BL/6 Mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Berberine; Cells, Cultured; Colitis, Ulcerative; C | 2015 |
Synthesis and Structure-Activity Relationships of N-Dihydrocoptisine-8-ylidene Aromatic Amines and N-Dihydrocoptisine-8-ylidene Aliphatic Amides as Antiulcerative Colitis Agents Targeting XBP1.
Topics: Amides; Amines; Animals; Berberine; Colitis, Ulcerative; DNA-Binding Proteins; Male; Molecular Struc | 2016 |
Versatile methods for synthesizing organic acid salts of quaternary berberine-type alkaloids as anti-ulcerative colitis agents.
Topics: Berberine; Colitis, Ulcerative; Hydrastis; Molecular Structure; Nuclear Magnetic Resonance, Biomolec | 2016 |
Evidence for the complementary and synergistic effects of the three-alkaloid combination regimen containing berberine, hypaconitine and skimmianine on the ulcerative colitis rats induced by trinitrobenzene-sulfonic acid.
Topics: Acetic Acid; Aconitine; Alkaloids; Analgesics; Animals; Antidiarrheals; Behavior, Animal; Berberine; | 2011 |
[Preparation and examination of the vitro releasing of pH-dependent kuijiekang tablet for colon-specific delivery].
Topics: Berberine; Colitis, Ulcerative; Colon; Delayed-Action Preparations; Drug Combinations; Drug Compound | 2007 |